Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

136 Views

152. New Vaccines: Friday, 12:15 - 1:30 p.m.

Poster Session: New Vaccines

(1637) Safety Evaluation of the Novel Oral Polio Vaccine Type 2 during a National Supplementary Immunisation Activity in Uganda, a Multipronged Approach: January–March 2022

Friday, October 13, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Fred Nsubuga, DM, MPH (he/him/his)

Senior Medicak Officer
Ministry of Health, Uganda, AFENET
Kampala, Wakiso, Uganda

ZG

Zunera Gilani, PhD, MPH

Epidemiologist
Centers for Disease Control and Prevention, Center for Global Health, Global Immunization Division
Baltimore, Maryland, United States
Farrell A. Tobolowsky, DO, MS

Epidemic Intelligence Service Officer
CDC
Atlanta, Georgia, United States
AL

Ashley T. Longley, MPH, MS

Epidemiologist
CDC
Atlanta, Georgia, United States
SG

Sharon A. Greene, Phd, MPH

Centers for Disease Control and Prevention
Atlanta, Georgia, United States
IN

Ismail Ntale, Bachelors of Pharmacy

Inspector of Drugs - Vaccine Pharmacovigilance
National Drug Authority
Kampala, Kampala, Uganda
NH

Ndagije Hellen, Pharmacy

National Drug Authority
Kampala, Wakiso, Uganda
AK

Annet Kisakye, MD

World Health Organisation
Kampala, Wakiso, Uganda
IA

Immaculate Ampaire, MD

Ministry of Health, Uganda
Kampala, Wakiso, Uganda
DK

Daniel Kyabayinze, PHD

Dr
Ministry of Health, Uganda
Kampala, Wakiso, Uganda
JG

Jane F. Gidudu, MD, MPH

US Centers for Disease Control and \prevention
Atlanta, Georgia, United States